1. Home
  2. SDSTW vs IMRN Comparison

SDSTW vs IMRN Comparison

Compare SDSTW & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stardust Power Inc. Warrant

SDSTW

Stardust Power Inc. Warrant

HOLD

Current Price

$0.20

Market Cap

13.3M

Sector

N/A

ML Signal

HOLD

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.80

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDSTW
IMRN
Founded
N/A
1994
Country
United States
Australia
Employees
8
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3M
12.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SDSTW
IMRN
Price
$0.20
$0.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.6K
73.6K
Earning Date
03-26-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,777,422.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.63
52 Week Low
$0.10
$0.68
52 Week High
$0.12
$2.39

Technical Indicators

Market Signals
Indicator
SDSTW
IMRN
Relative Strength Index (RSI) 56.45 34.26
Support Level $0.19 $0.89
Resistance Level $0.22 $1.05
Average True Range (ATR) 0.03 0.06
MACD 0.00 -0.01
Stochastic Oscillator 58.26 4.29

Price Performance

Historical Comparison
SDSTW
IMRN

About SDSTW Stardust Power Inc. Warrant

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: